Scibase AB Cash Flow Conversion Efficiency
Scibase AB cash flow conversion efficiency. Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -0.457x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-26.57 Million ≈ $-2.86 Million USD) by net assets (Skr58.11 Million ≈ $6.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Scibase AB (2012–2025)
Cash flow conversion efficiency of Scibase AB from 2012 to 2025. This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Scibase AB (SCIB) stock price for real-time trading data and today's change.
Scibase AB Cash Flow Conversion Ratio Explained
Scibase AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Scibase AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency. Also see SCIB stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Riley Gold Corp
V:RLYG
|
-0.026x |
|
Sebata Holdings Ltd
JSE:SEB
|
0.031x |
|
VOGO SA
PA:ALVGO
|
0.133x |
|
Ihlas Gazetecilik AS
IS:IHGZT
|
-0.003x |
|
ASIASOFT CORP.-NVDR-05
F:5ASA
|
0.039x |
|
Mg Internation
PA:ALMGI
|
-0.026x |
|
Chibougamau Independent Mines Inc
V:CBG
|
0.012x |
|
Welcron Hantec Co.Ltd
KQ:076080
|
-0.066x |
Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2025)
The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2025. Review SCIB free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr6.66 Million ≈ $716.29K |
Skr-84.58 Million ≈ $-9.10 Million |
-12.707x | -711.59% |
| 2024-12-31 | Skr36.65 Million ≈ $3.94 Million |
Skr-57.38 Million ≈ $-6.18 Million |
-1.566x | -29.68% |
| 2023-12-31 | Skr43.06 Million ≈ $4.63 Million |
Skr-51.98 Million ≈ $-5.59 Million |
-1.207x | +31.48% |
| 2022-12-31 | Skr25.24 Million ≈ $2.72 Million |
Skr-44.47 Million ≈ $-4.79 Million |
-1.762x | -215.78% |
| 2021-12-31 | Skr70.80 Million ≈ $7.62 Million |
Skr-39.50 Million ≈ $-4.25 Million |
-0.558x | +22.78% |
| 2020-12-31 | Skr46.86 Million ≈ $5.04 Million |
Skr-33.86 Million ≈ $-3.64 Million |
-0.723x | +39.05% |
| 2019-12-31 | Skr32.01 Million ≈ $3.45 Million |
Skr-37.96 Million ≈ $-4.08 Million |
-1.186x | -126.10% |
| 2018-12-31 | Skr71.48 Million ≈ $7.69 Million |
Skr-37.48 Million ≈ $-4.03 Million |
-0.524x | -37.36% |
| 2017-12-31 | Skr115.72 Million ≈ $12.45 Million |
Skr-44.18 Million ≈ $-4.75 Million |
-0.382x | -47.93% |
| 2016-12-31 | Skr185.41 Million ≈ $19.95 Million |
Skr-47.85 Million ≈ $-5.15 Million |
-0.258x | -61.43% |
| 2015-12-31 | Skr291.42 Million ≈ $31.36 Million |
Skr-46.59 Million ≈ $-5.01 Million |
-0.160x | +85.92% |
| 2014-12-31 | Skr32.65 Million ≈ $3.51 Million |
Skr-37.08 Million ≈ $-3.99 Million |
-1.136x | -20.76% |
| 2013-12-31 | Skr36.18 Million ≈ $3.89 Million |
Skr-34.03 Million ≈ $-3.66 Million |
-0.940x | -161.14% |
| 2012-12-31 | Skr-23.69 Million ≈ $-2.55 Million |
Skr-36.44 Million ≈ $-3.92 Million |
1.538x | -- |
About Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more